A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce prices. Here's what we know.

Danish company vies with US drugmaker for control of Metsera as they seek edge in growing market for weight-loss drugs

Gordon Findlay is a Novo Nordisk manager based in Switzerland who didn’t attend the White House’s Nov. 6 drug pricing announcement. Robert F. Kennedy Jr. wasn’t fleeing the scene, a White House spokesperson wrote on X; he was seeking medical attention for the man who fainted.

The stock price for Danish drugmaker Novo Nordisk ( NVO 2.06%) is down more than 8% since last Friday's close. What's going on with this former darling of the global pharmaceutical industry that surged in recent years to become Europe's most valuable company?

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce prices. Here's what we know.

Another quarterly earnings announcement from Novo Nordisk and another downgrade to earnings guidance from the Danish pharmaceuticals company, the fourth this year.

During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ongoing bidding war between Novo Nordisk and Pfizer over obesity biotech Metsera.

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was invited to the “Boundless Care, New Beginnings” 2025 Health Ecosystem Partner Alliance Summit and New Product Launch Ceremony,